Literature DB >> 31511220

[Protective effects of dexmedetomidine against pulmonary ischemia-reperfusion injury during cardiopulmonary bypass in rats].

Ge Cao1, Eryong Zhang1.   

Abstract

OBJECTIVE: To investigate the signaling pathways that mediate the protective effects of dexmedetomidine on lung tissue against ischemia-reperfusion (I/R) injury during cardiopulmonary bypass (CPB).
METHODS: Forty adult SD rats were randomized into 5 groups, namely I/R group (group A), dexmedetomidine group (group B), sham-operated group (group C), oxypenicillin group (group D), and oxypenicillin + dexmedetomidine group (group E). The arterial blood gas, lung tissue apoptosis rate, protein kinase (Akt), phosphorylated Akt (p-AKT), caspase-3 and caspase-9 were compared among the 5 groups.
RESULTS: In groups A, B, D and E, the heart rate (HR), mean arterial pressure (MAP), and oxygenation index (OI) measured before CPB, at opening of the left hilar and at the end of experiment decreased gradually while the respiratory index (RI) increased at the 3 time points. At the end of experiment, HR, MAP, and OI in group B were significantly higher and RI was significantly lower than those in groups A, D and E (P < 0.05). In groups A-E, the pathological scores of the lung tissue at the end of the experiment were 4.89, 1.89, 0, 6.01 and 5.76, respectively, and the cell apoptosis rates in the lung tissue were 6.25%, 3.69%, 1.06%, 8.06% and 7.79%, respectively (P < 0.001). Western blotting showed that the expressions of Akt and p-AKT were the highest and those of caspase-3 and caspase-9 were the lowest in group B among the 5 groups (P < 0.05).
CONCLUSIONS: Dexmedetomidine can effectively alleviate lung injury in rats during CPB possibly by targeting caspase-3 and caspase-9 proteins that are related to PI3K/Akt signaling pathway.

Entities:  

Keywords:  cardiopulmonary bypass; dexmedetomidine; lung injury

Mesh:

Substances:

Year:  2019        PMID: 31511220      PMCID: PMC6765602          DOI: 10.12122/j.issn.1673-4254.2019.08.16

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  20 in total

1.  Protective effect of dexmedetomidine in a rat model of α-naphthylthiourea-induced acute lung injury.

Authors:  Volkan Hanci; Gamze Yurdakan; Serhan Yurtlu; Işil Özkoçak Turan; Emine Yilmaz Sipahi
Journal:  J Surg Res       Date:  2012-03-09       Impact factor: 2.192

2.  Age-related effects of dexmedetomidine on myocardial contraction and coronary circulation in isolated guinea pig hearts.

Authors:  Maiko Hongo; Susumu Fujisawa; Takeshi Adachi; Tomonori Shimbo; Shigehiro Shibata; Takayoshi Ohba; Kyoichi Ono
Journal:  J Pharmacol Sci       Date:  2016-05-18       Impact factor: 3.337

Review 3.  Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis.

Authors:  Jen A Tan; Kwok M Ho
Journal:  Intensive Care Med       Date:  2010-04-08       Impact factor: 17.440

4.  Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells.

Authors:  Chenfang Luo; Dongdong Yuan; Weifeng Yao; Jun Cai; Shaoli Zhou; Yihan Zhang; Ziqing Hei
Journal:  Life Sci       Date:  2014-12-19       Impact factor: 5.037

5.  Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.

Authors:  Yong-Man Zhu; Can-Can Wang; Long Chen; Ling-Bo Qian; Lei-Lei Ma; Jing Yu; Man-Hua Zhu; Chuan-Yun Wen; Li-Na Yu; Min Yan
Journal:  Brain Res       Date:  2012-12-05       Impact factor: 3.252

6.  Effects of SDF-1/CXCR4 on Acute Lung Injury Induced by Cardiopulmonary Bypass.

Authors:  Hai Shi; Rujian Lu; Shuo Wang; Honglin Chen; Fei Wang; Kun Liu
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 7.  PI3K/AKT signaling pathway and cancer: an updated review.

Authors:  Miriam Martini; Maria Chiara De Santis; Laura Braccini; Federico Gulluni; Emilio Hirsch
Journal:  Ann Med       Date:  2014-06-05       Impact factor: 4.709

8.  Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass.

Authors:  Joanne Guay; Sandra Kopp
Journal:  Cochrane Database Syst Rev       Date:  2019-03-01

9.  Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass.

Authors:  Junbo Feng; Haiyuan Liu; Jiayi Chen; Jiyuan Wang; Zhuang Liu; Shenglin Ge
Journal:  Korean Circ J       Date:  2016-05-02       Impact factor: 3.243

10.  Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity.

Authors:  Yuan Peng; Haifeng Zhu; Haodong Chen; Zijin Zhu; Huahai Zhou; Shuguang Zhang; Lei Shi; Lili Gao; Xiaoliang Li; Zhengxiang Luo
Journal:  Oncotarget       Date:  2017-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.